Skip to main content
Log in

Myofibrillar protein structure and assembly during idiopathic dilated cardiomyopathy

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

A neutral protease, mekratin, active in human hearts at end stage idiopathic dilated cardiomyopathy (IDC), mediates the breakdown of cardiac myosin LC2. Myosin purified from IDC heart tissue forms unusually short synthetic thick filaments. Therefore, determination of filament length and mekratin distribution in IDC heart muscle were initiated. Native thick filaments were prepared directly from control and IDC tissues and analyzed. Also, paraffin-embedded tissue sections were stained with a fluorescently-labeled anti-protease antibody to establish its distribution in myocardial tissues. Control sections had only very weak, background levels of fluorescence whereas IDC sections stained intensely throughout, indicating a wide ranging distribution of the protease within the myocyte cytoplasm. SDS-PAGE revealed LC2 to be present in stoichiometric amounts in control but greatly reduced in IDC heart muscle. Native thick filaments from control myocardium were structurally stable. They had a median length of 1.65 μm with well-defined bare zones and displayed the 43 nm helical periodicity typical of the relaxed arrangement of myosin heads close to the filaments' shafts. In contrast, native IDC filaments were less stable, and had a median length of 0.9 μm. These filaments were highly disordered: they had no surface periodicity and myosin heads were positioned away from the filaments' shafts. The shorter, less stable, aperiodic thick filaments from IDC hearts appear to result from depletion of LC2 caused by increased activity of mekratin in the IDC myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bender JR: Idiopathic dilated cardiomyopathy: An immunologic, genetic or infectious disease, or all of the above? Circulation 83: 704–706, 1991

    PubMed  Google Scholar 

  2. Anderson JL, Carlquist JF, Hammond EH: Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. The Lancet 2: 1124–1127, 1982

    Google Scholar 

  3. Arbustini E, Gavazzi A, Pozzi R, Grasso M, Pucci A, Campana C, Graziano G, Martinetti M, Cuccia M, Salvaneschi L, Martinelli L, Montemartini C, Vigano M: The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 64: 991–995, 1989

    PubMed  Google Scholar 

  4. Carlquist LF, Menlove RL, Anderson JL: HLA class II (DR and DQ) antigen association in idiopathic dilated cardiomyopathy: Validation study and meta-analysis of published HLA association studies. Circulation 83: 515–522, 1991

    PubMed  Google Scholar 

  5. Mall G, Schwarz F, Derks H: Clinicopathologic correlations in congestive cardiomyopathy: A study of endomyocardial biopsies. Virchows Arch [Pathol Anat], 397: 67–82, 1982

    Google Scholar 

  6. Nakayama Y, Shimizu G, Hirota Y, Saito T, Kino M, Kitaura Y, Kawamura K: Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 10: 186–192, 1987

    PubMed  Google Scholar 

  7. Figulla HR, Rahlf G, Nieger M, Luig H, Kreuzer H: Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 71: 1095–1104, 1985

    PubMed  Google Scholar 

  8. Hammond EH, Menlove RL, Anderson JL: Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 114: 1055–1065, 1987

    PubMed  Google Scholar 

  9. Schaper J, Froede R, Buck A, Hashizume H, Speiser B, Briedl A, Bleese N: Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83: 504–514, 1991

    PubMed  Google Scholar 

  10. Hein S, Scholz D, Fujitani N, Rennollet H, Brand T, Friedl A, Schaper J: Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol 26: 1291–1306, 1994

    PubMed  Google Scholar 

  11. Wiegand V, Ebecke M, Figulla H, Schuler S, Kreuzer H: Structure and function of contractile proteins in human dilated cardiomyopathy. Clin Cardiol 12: 656–660, 1989

    PubMed  Google Scholar 

  12. Margossian SS, Slayter HS: Electron microscopy of cardiac myosin: Its shape and properties as determined by the regulatory light chain. J Muscle Res Cell Motil 8: 437–447, 1987

    PubMed  Google Scholar 

  13. Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slayter HS: Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: Identification of a causal agent for impaired myocardial function. Circulation 85: 1720–1733, 1992

    PubMed  Google Scholar 

  14. Margossian SS, Caulfield JB, Slayter HS: Activation of a protease during idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 26: S50/CXLVI, 1994

    Google Scholar 

  15. Margossian SS, White HD, Lefford J, Holt JC, Malhotra A, Stafford WF, Slayter HS: Functional effects of LC1-reassociation with cardiac papain MG-S1. J Muscle Res Cell Motil 14: 3–14, 1993

    PubMed  Google Scholar 

  16. Sellers JR: Phosphorylation-dependent regulation of Limulus muscle. J Biol Chem 256: 9274–9278, 1981

    PubMed  Google Scholar 

  17. Magid AH, Ting-Beall M, Carwell M, Kontis T, Lucaveche C: Connecting filaments, core filaments and side-struts: A proposal to add three new load-bearing structures to the sliding filament model. Adv Exp Med Biol 170: 307–328, 1984

    PubMed  Google Scholar 

  18. Wray JS, Goody R, Holmes KC: Towards a molecular mechanism for the cross-bridge cycle. Adv Exp Med Biol 226: 49–59, 1988

    PubMed  Google Scholar 

  19. Kensler RW, Stewart M: The relaxed crossbridge pattern in isolated rabbit psoas muscle thick filaments. J Cell Sci 105: 841–848, 1993

    PubMed  Google Scholar 

  20. Levine RJC, Kensler RW, Yang Z, Stull JT, Sweeney HL: Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J 71: 898–907, 1996

    PubMed  Google Scholar 

  21. Kensler RW, Levine RJC: An electron microscopic and optical diffraction analysis of the structure of Limulus thick filaments. J Cell Biol 92: 443–451, 1982

    PubMed  Google Scholar 

  22. Holt JC, Hatcher VB, Caulfield JB, Norton P, Umeda PK, Melendez JA, Martino L, Mudzinsky SP, Blumenstock F, Slayter HS, Margossian SS: Cloning of the cDNA and nucleotide sequence of a skeletal muscle protease from myopathic hamsters. Mol Cell Biochem 181: 125–135, 1998

    PubMed  Google Scholar 

  23. Liu F-T, Zinnecker M, Hamaska T, Katz DH: New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry 18: 690–697, 1979

    PubMed  Google Scholar 

  24. Slayter EM: Optical Methods in Biology. Wiley-Interscience, New York, 1970

    Google Scholar 

  25. Solaro RJ, Powers FM, Gao L, Gwathmey JK: Control of myofilament activation in heart failure. Circulation 87: 38–43, 1993

    PubMed  Google Scholar 

  26. Margossian SS, Huiatt TW, Slayter HS: Control of filament length by the regulatory light chains in skeletal and cardiac myosins. J Biol Chem 262: 5791–5796, 1987

    PubMed  Google Scholar 

  27. Chowrashi PK, Pemrick SM, Pepe FA: LC2 involvement in the assembly of skeletal myosin filaments. Biochim Biophys Acta 990: 216–223, 1989

    PubMed  Google Scholar 

  28. Dalla Libera L, Pauletto P, Piccolo D, Scannapieco G, Vescovo G: The idiopathic dilated cardiomyopathy in man. A biochemical and molecular study on myosin. Basic Res Cardiol 86: 70–78, 1991

    PubMed  Google Scholar 

  29. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM: Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathy: Role of altered b-adrenergically mediated protein phosphorylation. J Clin Invest 98: 167–176, 1996

    PubMed  Google Scholar 

  30. Corbett JM, Wheeler CH, Why HH, Richardson PJ, Yacoub MH, Dunn JJ: Studies on protein changes in dilated cardiomyopathy using twodimensional electrophoresis. J Mol Cell Cardiol 27: A110, 1995

    Google Scholar 

  31. Whiting A, Wardale J, Trinick JT: Does titin regulate the length of muscle thick filaments? J Mol Biol 168: 123–141, 1989

    Google Scholar 

  32. Margossian SS, Anderson PAW, Norton P, Caulfield JB, Chantler PD, Slayter HS: Ca2+-regulation and myofibrillar structure in human cardiomyopathic hearts. Biophys J 70: A160, 1996

    Google Scholar 

  33. Margossian SS, Anderson PAW, Norton P, Caulfield JB, Chantler PD, Slayter HS: Altered control of troponin T gene and increased activity of mekratin, a protease, in dilated cardiomyopathy. J Mol Cell Cardiol 27: A108, 1995

    Google Scholar 

  34. Levine RJC, Chantler PD, Kensler RW, Woodhead JL: Effects of phosphorylation by myosin light chain kinase on the structure of Limulus thick filaments. J Cell Biol 113: 563–572, 1991

    PubMed  Google Scholar 

  35. Saraswat I, Lowey S: Engineered cysteine mutants of myosin light chain 2. J Biol Chem 266: 19777–19785, 1991

    PubMed  Google Scholar 

  36. Yang Z, Stull JT, Sweeney HL: Potentiation of force in rabbit skeletal muscle via regulatory light chain phosphorylation is sarcomere length dependent. Biophys J 61: A267, 1992

    Google Scholar 

  37. Sweeney HL, Yang Z, Zhi G, Stull J, Trybus K: Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. Proc Natl Acad Sci USA 91: 1490–1494, 1994

    PubMed  Google Scholar 

  38. Rayment I, Rypniewski WR, Schmidt BK, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM: Threedimensional structure of myosin subfragment-1: A molecular motor. Science 261: 50–58, 1993

    PubMed  Google Scholar 

  39. Levine RJC, Yang Z, Sweeney HL: Effects of smooth muscle myosin light chain 2 exchanged into skinned skeletal fibers. Biophys J 72: A275, 1997

    Google Scholar 

  40. Lowey S, Waller GS, Trybus KM: Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature (London) 365: 454, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levine, R.J., Caulfield, J.B., Norton, P. et al. Myofibrillar protein structure and assembly during idiopathic dilated cardiomyopathy. Mol Cell Biochem 195, 1–10 (1999). https://doi.org/10.1023/A:1006940513097

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006940513097

Navigation